Constitutive activity of GPR26 regulated by ubiquitin-dependent degradation and its antitumor role

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• G protein-coupled receptors (GPCRs) are crucial in physiological functions and diseases.
• Many GPCRs exhibit constitutive activity, independent of ligand binding.
• Certain GPCRs, like GPR26, show low detectable protein levels (apparent state A) despite high constitutive activity.

Purpose of the Study:

• To investigate the mechanisms behind the low protein expression of certain GPCRs.
• To characterize the functional significance of GPR26's actual expression level (actual state B).
• To explore the potential of GPR26 as an antitumor agent in liver cancer.

Main Methods:

• Cell lysis in the presence of western blot loading buffer to determine actual protein levels (actual state B).
• Identification of ubiquitination sites and interacting ubiquitin ligases for GPR26.
• In vitro and in vivo assays to assess the antitumor activity of GPR26.

Main Results:

• Lysis in loading buffer revealed significantly higher GPR26 protein levels (actual state B) compared to standard lysis (apparent state A).
• Ubiquitination at K286 and interaction with E3 ubiquitin ligase homologous to E6-associated protein carboxyl terminus domain containing 3 were identified as key to GPR26 degradation.
• High expression and constitutive activity of GPR26 demonstrated in vitro and in vivo antitumor effects in liver cancer cells.

Conclusions:

• GPCRs, including GPR26, are subject to rapid ubiquitin-mediated degradation, influencing their apparent expression and activity.
• GPR26 exhibits significant antitumor activity against hepatocellular carcinoma.
• GPR26 represents a potential therapeutic target for liver cancer due to its constitutive activity and antitumor properties.